With a mission to create A Healthier World, University Health Network (UHN) is at the forefront of healthcare research and innovation. UHN comprises four academic hospitals, an education institute, a technology accelerator and six research institutes. Research is supported in part by UHN Foundation and The Princess Margaret Cancer Foundation.
UHN’s research institutes are epicenters of groundbreaking research across diverse disciplines.
At the Princess Margaret Cancer Centre, one of the largest integrated cancer research, teaching and treatment centres in Canada, a team of dedicated researchers seeks to understand all aspects of cancer. In recent achievements, researchers have brought a new anticancer drug closer to clinical application and uncovered protein structures that can be used as drug targets.
The KITE Research Institute is a world leader in complex rehabilitation, with scientists dedicated to improving the lives of people living with the effects of disability, illness and aging. Recent work has shown how the connection between the brain and hand muscles can predict recovery after spinal cord injury and how mixed reality technology can be used to improve the lives of individuals with dementia.
The Toronto General Hospital Research Institute has contributed to therapeutic advances in organ transplantation, cardiac pacemakers and novel therapies in endocrine and autoimmune disorders. Most recently, researchers developed a technology to predict a patient’s risk of severe outcomes from infection and worked with Indigenous populations towards the goal of eliminating Hepatitis C in Canada.
The Krembil Research Institute is dedicated to developing innovative treatments for chronic debilitating conditions that include neurological, ophthalmologic and musculoskeletal system disorders. Recent advancements include discovering biomarkers for a form of arthritis and improving vision loss with a new rehabilitation method.
The Institute for Education Research strives to support and advance the healthcare system through developing and implementing new ways of educating the healthcare workforce. Research has identified gaps in oncology training and education for family physicians and challenges in care that occur due to staff changeovers during surgery.
The McEwen Stem Cell Institute is on a mission to develop new stem cell–based therapies for chronic diseases with unmet clinical needs such as blood cancers, diabetes and heart and liver disease. Researchers continue to explore methods for cell therapy, a potential future treatment for these diseases.
Looking to the future with AI
As artificial intelligence (AI) continues to revolutionize healthcare, UHN is committed to leading the way during this transformation. UHN has appointed an inaugural chief AI scientist and launched Canada’s first AI Hub. This collaborative centre, uniting experts across medical research, is aimed at generating more accessible, efficient and personalized healthcare through AI technology.
UHN’s researchers have already begun using AI to enhance patient care—including ways to assist with cardiovascular, organ transplantation and virtual cancer care. Additionally, UHN partnered with Mayo Clinic’s Platform_Connect, a global data network to accelerate data science and AI-driven healthcare solutions.
With the potential to improve patient outcomes, UHN is looking to the future with AI.
University Health Network is a Member of Research Canada: An Alliance for Health Discovery and a Sponsor of the Parliamentary Health Research Caucus Luncheon Celebrating the 2023 Gairdner Awards and Aligning First Nations’ Values in Indigenous Mental Health, Substance Use, Trauma and General Wellness: A Virtual Discussion with Dr. Christopher Mushquash. Visit rc-rc.ca to learn more.